ESC 365 - Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model

ESC Premium Access

Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model

Session: The broad spectrum of cardiovascular risk

Topic: Cardiovascular Risk Assessment

Speaker: Mr J. Holtrop (Utrecht, NL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Joris Holtrop

Utrecht (Netherlands (The))

0 follower

5 more presentations in this session

Heterogeneous effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular events among people with type 2 diabetes: an application of machine learning to target trial emulation

Speaker: Doctor Y. Mori (Kyoto, JP)

Red cell distribution width as a predictor of cardiovascular events in high-risk patients with statin intolerance: post-hoc analysis of the CLEAR Outcomes trial

Speaker: Doctor P. Moriarty (Kansas City, US)

High physical activity relates to higher risk of incident carotid plaque components

Speaker: Mr L. Zuo (Rotterdam, NL)

Sex-differences in prescription patterns of secondary prevention pharmacotherapy in patients with acute myocardial infarction: a 20-year perspective

Speaker: Professor H. Rickli (St. Gallen, CH)

Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes mellitus: systematic review and meta-analysis

Speaker: Doctor R. Sun (Beijing, CN)

Access the full session

The broad spectrum of cardiovascular risk

Speakers: Mr J. Holtrop, Doctor Y. Mori, Doctor P. Moriarty, Mr L. Zuo, Professor H. Rickli...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources